Bio Medica Laboratories Limited IPO

Incorporated in August 2015, Bio Medica Laboratories specialises in manufacturing pharmaceutical parenteral formulations, producing a wide range of ethical drugs, generic drugs, and over-the-counter (OTC) medications in liquid and dry-powder injectable forms.der injectables. These injectables are available in both single-dose and multi-dose formats, serving the needs of both human and veterinary healthcare. Product portfolio: Liquid Injectables: 58 products are offered under this category Dry powder injectables: 15 products under this category It offers comprehensive range of products, including generic drugs, branded pharmaceuticals, over the counter (OTC) products, and other medications. The company operates on a B2B model, focusing exclusively on contract manufacturing. It develop formulations for various companies in accordance with their specific requirements and product specifications. It is certified for Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP) certificate issued by the Food & Drugs Administration, Madhya Pradesh. It has two manufacturing facilities in Indore, Madhya Pradesh. Competitive Strengths Multi-product capability and diversified product portfolio Experienced promoters, management and employees. Quality assurance Established client relationship

Repayment of loan Enhancement of its existing production capabilities by setting up of new manufacturing facility at the existing premises General Corporate Purposes Total